Adenosine

5'-nucleotidase ecto ; Homo sapiens







542 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34393062 Arginase Pathway Markers of Immune-Microenvironment in Thymic Epithelial Tumors and Small Cell Lung Cancer. 2022 Mar 1
2 34922916 Crowding within synaptic junctions influences the degradation of nucleotides by CD39 and CD73 ectonucleotidases. 2022 Jan 18 2
3 34961895 Mono-ADP-ribosylation sites of human CD73 inhibit its adenosine-generating enzymatic activity. 2022 Mar 6
4 35064653 Dynamic Adjust of Non-Radiative and Radiative Attenuation of AIE Molecules Reinforces NIR-II Imaging Mediated Photothermal Therapy and Immunotherapy. 2022 Mar 1
5 35078640 Downregulation of CD73 on CD4+ T cells from patients with chronic Chikungunya infection. 2022 Apr 2
6 35196024 Operational tolerance after hematopoietic stem cell transplantation is characterized by distinct transcriptional, phenotypic, and metabolic signatures. 2022 Feb 23 3
7 35199627 Variability in CD39 and CD73 protein levels in uveal melanoma patients. 2022 Feb 24 1
8 35217359 Discovery and optimization of betulinic acid derivatives as novel potent CD73 inhibitors. 2022 Apr 1 3
9 35218567 Amniotic fluid stem cell-derived extracellular vesicles are independent metabolic units capable of modulating inflammasome activation in THP-1 cells. 2022 Apr 2
10 35222389 CD39/CD73 Dysregulation of Adenosine Metabolism Increases Decidual Natural Killer Cell Cytotoxicity: Implications in Unexplained Recurrent Spontaneous Abortion. 2022 4
11 35325005 Elevated ATP via enhanced miRNA-30b, 30c, and 30e downregulates the expression of CD73 in CD8+ T cells of HIV-infected individuals. 2022 Mar 1
12 35327609 Adenosine-Metabolizing Enzymes, Adenosine Kinase and Adenosine Deaminase, in Cancer. 2022 Mar 8 1
13 35365585 Genetic characteristics involving the PD-1/PD-L1/L2 and CD73/A2aR axes and the immunosuppressive microenvironment in DLBCL. 2022 Apr 1
14 35365613 Identification and validation of ecto-5' nucleotidase as an immunotherapeutic target in multiple myeloma. 2022 Apr 1 2
15 35371066 Adenosinergic Pathway and Linked Suppression: Two Critical Suppressive Mechanisms of Human Donor Antigen Specific Regulatory T Cell Lines Expanded Post Transplant. 2022 1
16 35405741 Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity. 2022 Jun 1 4
17 35444646 Decreased CD73+ Double-Negative T Cells and Elevated Level of Soluble CD73 Correlated With and Predicted Poor Immune Reconstitution in HIV-Infected Patients After Antiretroviral Therapy. 2022 2
18 35479074 Extracellular cAMP-Adenosine Pathway Signaling: A Potential Therapeutic Target in Chronic Inflammatory Airway Diseases. 2022 2
19 35508221 Combination of oxaliplatin and POM-1 by nanoliposomes to reprogram the tumor immune microenvironment. 2022 May 4 1
20 35510041 Head and Neck Squamous Cell Carcinoma: NT5E Could Be a Prognostic Biomarker. 2022 4
21 35563517 CD73/Adenosine Pathway Involvement in the Interaction of Non-Small Cell Lung Cancer Stem Cells and Bone Cells in the Pre-Metastatic Niche. 2022 May 4 1
22 35563553 Tumor Infiltration with CD20+CD73+ B Cells Correlates with Better Outcome in Colorectal Cancer. 2022 May 5 1
23 35573239 CD73-Positive Small Extracellular Vesicles Derived From Umbilical Cord Mesenchymal Stem Cells Promote the Proliferation and Migration of Pediatric Urethral Smooth Muscle Cells Through Adenosine Pathway. 2022 2
24 35598361 The regulation of CD73 in non-small cell lung cancer. 2022 May 19 1
25 35620732 The Effects of CD73 on Gastrointestinal Cancer Progression and Treatment. 2022 1
26 35622118 Functional expression of CD73 on human natural killer cells. 2022 May 25 1
27 32203145 Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for their immunosuppressive function. 2021 Jan 2
28 32648591 The role of the CD39-CD73-adenosine pathway in liver disease. 2021 Feb 6
29 32961376 Paradoxical Regulation of Allogeneic Bone Marrow Engraftment and Immune Privilege by Mesenchymal Cells and Adenosine. 2021 Jan 1
30 32970335 CD73 contributes to anti-inflammatory properties of afferent lymphatic endothelial cells in humans and mice. 2021 Jan 1
31 32981507 Identification and Expression Analysis of CD73 Inhibitors in Cervical Cancer. 2021 2
32 33098857 B cells from Patients with Rheumatoid Arthritis Show Conserved CD39-Mediated Regulatory Function and increased CD39 Expression After Positive Response to Therapy. 2021 Jan 8 1
33 33123998 Adenosine Signaling in the Tumor Microenvironment. 2021 1
34 33161021 Extracellular adenosine 5'-triphosphate in pulmonary disorders. 2021 May 2
35 33222670 Targeting Tumor-derived Exosomes Expressing CD73: New Opportunities in the Pathogenesis and Treatment of Cancer. 2021 2
36 33268695 Involvement of CD73 and A2B Receptor in Radiation-Induced DNA Damage Response and Cell Migration in Human Glioblastoma A172 Cells. 2021 Feb 1 3
37 33340515 Adenosine metabolism in the vascular system. 2021 May 3
38 33399453 Discovery of Potent and Selective Methylenephosphonic Acid CD73 Inhibitors. 2021 Jan 14 3
39 33416944 CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma. 2021 Jul 2
40 33416945 Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1/Anti-CTLA4 antibodies and shorter survival. 2021 Jul 1
41 33430239 CD73, Tumor Plasticity and Immune Evasion in Solid Cancers. 2021 Jan 7 2
42 33433704 Loss of stromal CD73 expression plays a role in pathogenesis of polypoid endometriosis. 2021 Jun 1
43 33434633 CD73 and cN-II regulate the cellular response to chemotherapeutic and hypoxic stress in lung adenocarcinoma cells. 2021 May 1
44 33460629 Targeting ectonucleotidases to treat inflammation and halt cancer development in the gut. 2021 May 2
45 33482152 Extracellular purines and bone homeostasis. 2021 May 2
46 33564128 Modulatory activity of adenosine on the immune response in cord and adult blood. 2021 Nov 1
47 33579783 Blocking CD73 Can Shrink Pancreatic Tumors. 2021 May 1
48 33609609 Loss of CD73 shifts transforming growth factor-β1 (TGF-β1) from tumor suppressor to promoter in endometrial cancer. 2021 May 1 2
49 33610376 Targeting adenosine and regulatory T cells in cancer immunotherapy. 2021 Apr 2
50 33727591 CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer. 2021 Mar 16 1